Description

• NovoRapid insulin pen 5’ct Imported Turkey is a fast-acting insulin injection used to manage blood sugar levels in individuals with diabetes. The Flexpen design allows for easy and convenient dosing, with a dial to adjust the amount of insulin needed. It has a small and discreet size, making it easy to carry.NovoRapid Flexpen 100 U/ml is available in Pakistan and starts working quickly to lower blood sugar levels, making it an effective option for managing post-meal blood sugar spikes. However, it should be used with caution as it may cause serious side effects, including:
  • Allergic reactions in individuals allergic to any of the ingredients
  • Hypoglycemia (low blood sugar) or diabetic ketoacidosis
  • Interactions with

  certain medications

It is important to closely monitor blood sugar levels, have a source of glucose on hand, and follow healthcare provider instructions when using NovoRapid Flexpen. Any unusual symptoms or side effects should be reported to a healthcare pr

ofessional immediately.

Rapid-Acting Insulin

NovoRapid is a rapid-acting insulin analog that starts working quickly to lower blood sugar levels after meals. It reaches its peak effect within 1-2 hours and has a shorter duration of action compared to regular human insulin.

FlexPen Design

The NovoRapid insulin pen comes in a FlexPen design that is easy to use and discreet. The pen is small, lightweight, and durable, making it convenient to carry. It has a simple dial to select the desired dose.

Imported from Turkey

This particular pack of NovoRapid insulin pens is imported from Turkey. The quality and composition of the insulin is the same as other NovoRapid products, but it may have Turkish labeling and packaging.

5-Pack

The pack contains 5 pre-filled NovoRapid insulin pens. Each pen contains 300 units of insulin and can deliver doses from 1 to 60 units in 1-unit increments.

Sterile and Disposable

The NovoRapid FlexPen is a sterile, single-patient-use, disposable device. It should be discarded after use and never shared with others.

Refrigeration Required

NovoRapid insulin should be stored in a refrigerator at 2°C to 8°C. Once in use, the pen can be kept at room temperature (below 30°C) for up to 4 weeks.Always consult with a healthcare professional before using any insulin product and follow their instructions for proper dosage, administration, and storage.

Key Benefits

• Rapid-acting insulin that starts lowering blood sugar levels within 10-20 minutes of injection
• Reaches peak effect in 1-3 hours and lasts for up to 5 hours
• Convenient FlexPen design with a dial to easily select the desired dose
• Small, lightweight, and discreet pen that is easy to carry
• Sterile, single-patient-use, disposable pen

Key Ingredients

The active ingredient in NovoRapid is insulin aspart. The non-medicinal ingredients include:

• Glycerol
• Phenol
• Metacresol
• Zinc chloride
• Sodium chloride
• Disodium phosphate dihydrate
• Sodium hydroxide
• Hydrochloric acid
• Water for injection

NovoRapid insulin aspart is a rapid-acting insulin analog that is very similar to the insulin produced naturally by the body. It helps lower blood sugar levels by facilitating glucose entry into cells from the blood.The combination of rapid action, convenient delivery, and high quality ingredients makes NovoRapid an effective option for managing diabetes and controlling blood sugar levels.                                                                                                                                    The mechanism of action of NovoRapid (insulin aspart) is as follows:NovoRapid is a rapid-acting insulin analog that works by facilitating the uptake of glucose into cells, particularly in muscle and fat tissue, and inhibiting glucose production by the liver. This results in lowered blood glucose levels.Insulin aspart binds to the insulin receptor, a protein consisting of two alpha and two beta subunits. Binding activates the receptor’s tyrosine kinase activity, leading to phosphorylation of intracellular substrates like insulin receptor substrate (IRS) proteins. This triggers downstream signaling through PI3 kinase and Akt pathways.Akt regulates glucose transporter 4 (GLUT4) and protein kinase C (PKC), which are critical for glucose metabolism and storage. Insulin also promotes energy storage as glycogen and opposes breakdown of energy reserves.The single amino acid substitution of proline to aspartic acid at position B28 in insulin aspart reduces its tendency to form hexamers. This allows insulin aspart to be absorbed more rapidly from the subcutaneous injection site compared to regular human insulin.NovoRapid starts lowering blood glucose within 10-20 minutes of injection, peaks in 1-3 hours, and has a duration of action of 3-5 hours. This rapid onset and short duration mimics the natural insulin response to meals better than regular insulin.

Insulin aspart

Modified type of medical insulin used to treat type 1 and type 2 diabetes

More

Trade names

NovoLog, NovoRapid, Fiasp, others

Biosimilars

Kirsty, Trurapi, Truvelog

Pregnancy category

AU: A

Dosage

• The dosage of insulin aspart is determined by the physician according to the patient’s individual needs
• The individual insulin requirement in adults and children is usually between 0.5 and 1.0 U/kg/day
• In a basal-bolus treatment regimen, 50-70% of the total dose may be provided by NovoRapid and the remainder by intermediate-acting or long-acting insulin
• NovoRapid should be taken immediately before a meal, with the start of the meal not more than 5-10 minutes after injection

Storage

• NovoRapid should be stored between 2°C and 8°C (refrigerator). Do not freeze
• Once in use, the pen can be kept at room temperature (below 30°C) for up to 4 weeks
• NovoRapid must be protected from excessive heat and light
• Discard NovoRapid FlexPen after 4 weeks even if there is still some insulin left

Reviews

The search results do not contain any specific reviews for NovoRapid insulin pen 5’ct Imported Turkey. However, some general points about NovoRapid can be inferred:

• NovoRapid is an effective rapid-acting insulin analog for managing diabetes
• It has a faster onset and shorter duration of action compared to regular human insulin
• NovoRapid is well-tolerated, but hypoglycemia is the most common adverse effect
• Overall, NovoRapid provides good glycemic control when used as directed by a healthcare professional